ÂÜÀòÂÒÂ×

Sheila Gujrathi, MD, currently serves as Executive Chair of the Board of Directors at Ventyx Biosciences and holds the position of Chair of the Board of Directors at both IMMPACT BIO and ADARx Pharmaceuticals Inc. Additionally, Sheila Gujrathi is a Director on the Board of Directors at Janux Therapeutics and a Venture Advisor at OrbiMed. Sheila Gujrathi completed the Seven Year Honors Program in Medical Education at Northwestern University, earning a B.S. with Highest Distinction, followed by an M.D. from Northwestern University's Feinberg School of Medicine.